1-(1-Boc-3-azetidinyl)-4-ethynylpyrazole

Catalog No.: 
ACJUTK643
CAS No.: 
2098140-87-3
Molecular Formula: 
C13H17N3O2
Molecular Weight: 
247.30
1-(1-Boc-3-azetidinyl)-4-ethynylpyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$302.00InquiryInquiry
100mg98%$442.00InquiryInquiry
250mg98%$623.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(1-Boc-3-azetidinyl)-4-ethynylpyrazole
IUPAC Nametert-butyl 3-(4-ethynyl-1H-pyrazol-1-yl)azetidine-1-carboxylate
MDL No.MFCD30484450
Molecular FormulaC13H17N3O2
Molecular Weight247.30
SMILESC#CC1=CN(C2CN(C(OC(C)(C)C)=O)C2)N=C1
InChI KeyAEWFIEXPPDMJOZ-UHFFFAOYSA-N
Synonym1-(1-Boc-3-azetidinyl)-4-ethynylpyrazole;tert-butyl 3-(4-ethynyl-1H-pyrazol-1-yl)azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-(4-ethynyl-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester
CAS No.2098140-87-3

Safety Data

Pictogram
PICTOGRAM
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJUTK643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACECIM271 route compound structure diagram
    ACECIM27157121-49-0In Stock
  2. Plus
  3. ACUMRD963 route compound structure diagram
    ACUMRD963141699-58-3In Stock
  4. Then
  5. ACJUTK643 route product structure diagram
    ACJUTK6432098140-87-3
Inquiry

2. ACJUTK643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJUTK643 route product structure diagram
    ACJUTK6432098140-87-3
Inquiry

3. ACJUTK643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJUTK643 route product structure diagram
    ACJUTK6432098140-87-3
Inquiry

Comments (0)